Publications by authors named "Da-Feng Mao"
Article Synopsis
- DEB-TACE, known for its steady drug release and low side effects, shows promising results when combined with radiofrequency ablation (RFA) for treating primary hepatocellular carcinoma (HCC).
- A study involving 76 patients aimed to assess the treatment's efficacy and survival outcomes, comparing those with untreated HCC (Group A) and hepatectomy patients (Group C).
- Results indicated similar treatment effectiveness between Groups A and C, with Group A showing lower liver enzyme levels and absence of operational-related deaths, suggesting DEB-TACE combined with RFA is a viable option for HCC management with potential benefits.
Article Synopsis
- RFA (Radiofrequency Ablation) is effective for localized tumor destruction in patients with recurrent colorectal liver metastases who are not candidates for surgery, but studies show it may be less effective than hepatic resection.
- A study compared outcomes of patients undergoing RFA versus repeat hepatic resection, finding no significant differences in liver function, complication rates, or long-term survival.
- Overall, both treatments present viable options, but RFA has the advantage of lower complications, making it a safe choice for certain patients.
Aim: To explore the relationship of liver and spleen shear wave velocity in patients with liver cirrhosis combined with portal hypertension, and assess the value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension.
Methods: All 67 patients with liver cirrhosis diagnosed as portal hypertension by hepatic venous pressure gradient in our hospital from June 2014 to December 2014 were enrolled into this study. The baseline information of these patients was recorded.